Benitec Biopharma reported financial results for the fiscal year ended June 30, 2026, ending the period with approximately $180 million in cash. The company provided a clinical update on its BB-301 program for OPMD-related dysphagia, noting that Cohort 2 is fully enrolled and a pivotal study is planned for initiation in mid-2027 following a Type C meeting with the FDA.
Term
FY2026
“This has been an important year of clinical execution for Benitec and for the continued development of BB-301. Over the course of the year, we completed the follow-up of all six patients in Cohort 1 and fully enrolled Cohort 2, while continuing the regulatory interactions required to prepare BB-301 for advancement into a pivotal trial.”
Jerel A. Banks, M.D., Ph.D., Executive Chairman and Chief Executive Officer
“The consistency and durability of the clinical benefit observed to date, together with the discussions we have had with the FDA regarding pivotal study plans, continue to strengthen our conviction in the potential of BB-301 to meaningfully alter the course of OPMD-related dysphagia.”
Jerel A. Banks, M.D., Ph.D., Executive Chairman and Chief Executive Officer
Kestra Medical Technologies reported first quarter fiscal 2027 revenue of $31.0 million, a 60% increase year-over-year, driven by wearable cardioverter defibrillator (WCD) market expansion and competitive gains. The company reported a GAAP net loss of $44.1 million and increased its full-year fiscal 2027 revenue guidance to $141 million.
Term
Q1 2027
Earnings call
Sep 14, 2026, 4:30 PM ET
“Kestra delivered another strong quarter of financial performance, generating revenue growth of 60% while expanding gross margin to over 56%. We remain confident that our focus on innovation and commercial expansion positions Kestra to generate durable, top-tier growth for years to come. Our team is executing on its commitments to prescribers and their patients and we believe this will continue to drive market expansion and advance Kestra on its path to market leadership.”
Immersion Corporation reported Q1 fiscal 2027 total revenues of $294.4 million and GAAP net income of $4.9 million, or $0.17 per diluted share. The results include the consolidated financial information of Barnes & Noble Education, in which Immersion holds a 32.3% stake. The company also declared its sixteenth consecutive quarterly dividend of $0.075 per share.
Term
Q1 2027
“Our fiscal year is off to a strong start. While financial performance can be lumpy, we continue to be focused on executing against strategic initiatives that will drive long-term shareholder value.”
RF Industries reported record third-quarter fiscal 2026 net sales of $23.96 million, a 21% year-over-year increase. Net income rose 267% to $1.44 million, or $0.12 per diluted share, driven by a shift toward higher-value custom cabling and integrated systems solutions. The company ended the quarter with a backlog of $18.6 million and reported significant margin expansion to 35.6%.
Term
Q3 2026
Earnings call
Sep 14, 2026, 8:30 AM ET
“The RFI team delivered another quarter of accelerating topline growth by converting stronger demand into expanding margins and dramatically higher profitability, as well as demonstrating the earnings power of the business as revenue scales above the $20 million quarterly run rate.”
Robert Dawson, Chief Executive Officer of RF Industries
“Our steady margin expansion is a direct result of successfully executing a multi-year mix shift toward higher-value solutions, including our custom cabling and integrated systems offerings. These solutions have more engineering content, larger project scope, and engender stronger customer relationships than traditional component sales.”
Robert Dawson, Chief Executive Officer of RF Industries
AMREP Corporation reported financial results for its first fiscal quarter ended July 31, 2026, with revenues of $6.1 million compared to $17.9 million in the prior year period. Net income decreased significantly to $276,000, or $0.05 per diluted share, from $4.7 million in the same quarter of the previous year.
National Beverage Corp. reported Q1 2026 net sales of $331 million and earnings per share of $0.50. Results were impacted by elevated aluminum commodity costs and tariffs, which negatively affected gross margin by approximately 600 basis points. The company also highlighted the payment of a $304 million special dividend ($3.25 per share) during the quarter.